Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKelso Grp Hldg Regulatory News (KLSO)

Share Price Information for Kelso Grp Hldg (KLSO)

Share Price is delayed by 15 minutes
Get Live Data
3.30    0.00 (0.00%)
Bid:
2.80
Ask:
3.30
Spread: 0.50 (17.857%)
Market Cap: £15.31m
KLSO Live PriceLast checked at - London Stock Exchange

Intraday Kelso Grp Hldg Share Chart

NED Appointments to The Works

14 Feb 2024 07:01

RNS Number : 0424D
Kelso Group Holdings PLC
14 February 2024
 

14 February 2024

 

Kelso Group Holdings Plc ("Kelso" or the "Company")

NED Appointments to The Works

 

Kelso, the main market listed acquisition vehicle, notes the following announcement from TheWorks.co.uk plc ("The Works") today regarding changes to its Board.

 

The Works, the family-friendly value retailer of books, arts and crafts, stationery, toys and games, announces the appointment of John Goold and Mark Kirkland as Non-Independent Non-Executive Directors effective immediately.

John Goold is Chief Executive Officer and Mark Kirkland is Chief Financial Officer at Kelso Group Holdings plc, an investment company that seeks to identify, engage and unlock trapped value in the UK stock market. Kelso have been investors in The Works since September 2023 and on 30 October 2023 announced a holding in The Works of 5.1%. John and Mark will become members of the Board but, as Non-Independent Directors, will not join any committees. Their focus will be on all matters relating to shareholder value.

The Works has consulted with certain of its major shareholders, who are supportive of these appointments.

Carolyn Bradley, Chair of The Works, said: "I am pleased to welcome John and Mark to the Board following Kelso's investment in The Works last year. They bring extensive corporate and operational experience at Board level and will be an asset to The Works as we continue to deliver our 'Better, not just Bigger' strategy. We are grateful for their ongoing support and look forward to working together to drive shareholder value."

John Goold and Mark Kirkland jointly stated: "We have long believed that The Works has a strong customer proposition, a broad range of products with plenty of appeal and an important focus on affordability. By joining the Board we can bring our experience, particularly working with listed small cap businesses, to drive shareholder value. We are supportive of both management and the strategic direction of the business and look forward to helping to restore the intrinsic valuation of The Works, which we believe is much higher than the current share price reflects."

Biographies:

John Goold is Chief Executive Officer at Kelso Group Holdings plc. He qualified as a chartered accountant in London with Touche Ross in 1996 before a 25-year career in the City raising growth capital and advising small and mid cap companies. John initially started in corporate finance before moving into equity sales and corporate broking where he spent most of his career advising smaller listed companies on stock market issues. During his career, John has helped raise over £5.0 billion for his clients much of which was while he was Chief Executive of Zeus from 2012 to 2021. He is currently a non-executive director of Oncimmune Holdings plc and Boohoo Group plc.

Mark Kirkland is Chief Financial Officer at Kelso Group Holdings plc. He qualified as a chartered accountant with Price Waterhouse Coopers in London and has gained extensive corporate experience gained over 30 years having held numerous senior roles in public and private companies. Mark's initial career was in corporate finance predominantly with UBS. Mark has been CFO of numerous public and private companies and latterly was CEO of Delin Property, a pan European Logistics developer, investor and manager. He is currently a Non-Executive Director at Strix Group plc and AEW UK REIT plc and previously an adviser to DP World.

 

For further information please contact:

Kelso Group Holdings plc

+44 (0) 75 4033 3933

John Goold, Chief Executive Officer

Mark Kirkland, Chief Financial Officer

Jamie Brooke, Chief Investment Officer

Zeus (Broker)

+44 (0) 20 3829 5000

Nick Cowles, Ed Beddows (Investment Banking)

Ben Robertson (Corporate Broking)

 

About Kelso

Kelso was established in 2022 to identify, engage and unlock trapped value in the UK stock market. Kelso's strategy is to invest in situations where there is an anomaly between the intrinsic value and prospects of a company and its stock market valuation. Kelso will, in particular, look for situations where it believes the sum of the parts of a business is greater than the current value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREAFADFAALEAA
12
Date   Source Headline
5th Jun 20267:00 amRNSPortfolio update
28th May 20267:00 amRNSNotice of AGM
22nd May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of Placing and Subscription
13th May 20267:00 amRNSProposed Placing and Subscription
30th Apr 20267:00 amRNSFY25 Results
27th Apr 20267:00 amRNSNew investment in Filtronic plc
22nd Apr 20265:33 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
27th Feb 20265:36 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSUpdate on Investment: TheWorks.co.uk Plc
20th Feb 20267:00 amRNS-RYellowstone Advisory Presentation
17th Feb 20267:00 amRNSNew investment in CVS Group plc
22nd Jan 20267:00 amRNSUpdate on Investment in NCC Group plc
15th Jan 20269:55 amRNSNotification of Major Holdings
6th Jan 20267:00 amRNSNew investment in Saga plc
17th Dec 20257:00 amRNSResult of Placing and Subscription
16th Dec 20257:00 amRNSUpsizing of Placing and Subscription
15th Dec 20254:35 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim results for six months ended 30 June 2025
25th Jun 20254:17 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Update
30th May 20259:06 amRNSNotice of AGM
23rd May 20257:15 amRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSPurchase of Shares & PDMR Shareholding
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSFY24 Results
27th Nov 20247:00 amBUSHolding(s) in Company
7th Nov 20247:00 amRNSOliver Hemsley Appointment & Selkirk IPO Update
17th Oct 20247:00 amRNSUpdate on Kelso Investments
10th Oct 20245:00 pmRNSComment on THG Plc
1st Oct 20248:00 amRNSListing Rule 9.6.14(1) announcement
30th Sep 20247:00 amRNSInterim results for six months ended 30 June 2024
16th Aug 20247:00 amRNSUpdate on Investment in NCC Group Plc
2nd Aug 20247:00 amRNSUpdate on Investment in NCC
7th Jun 20247:00 amRNSNotification of Major Holdings
4th Jun 20247:00 amRNSNotification of Major Holdings
30th May 20244:00 pmRNSResult of AGM
30th May 20247:00 amRNSAGM Trading Update
21st May 20247:00 amRNSVoting intentions at THG AGM
8th May 202411:44 amRNSConfirmation of Accounts and Notice of AGM
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:02 amRNSFurther investment in NCC Group Plc
30th Apr 20247:00 amRNSFull-year results for 12 months ended 31 Dec 2023
4th Apr 20248:00 amRNSNotice of Results
14th Mar 20247:00 amRNSNotification of Major Holdings
14th Feb 20247:01 amRNSNED Appointments to The Works
14th Feb 20247:00 amRNSNotification of Major Holdings
30th Jan 20247:00 amRNSNotification of Major Holdings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.